Report: Phase 2 data will continue to dominate biotech venture capital investment in 2025

By 2025, enterprise capital traders are anticipated to prioritize corporations that attain part 2 and past, in line with funding service Pitchbook.

发布者:BY ANNE GRETE STORVIK,转转请注明出处:https://robotalks.cn/report-phase-2-data-will-continue-to-dominate-biotech-venture-capital-investment-in-2025/

(0)
上一篇 30 12 月, 2024 8:19 下午
下一篇 30 12 月, 2024 8:19 下午

相关推荐

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注

联系我们

400-800-8888

在线咨询: QQ交谈

邮件:admin@example.com

工作时间:周一至周五,9:30-18:30,节假日休息

关注微信
社群的价值在于通过分享与互动,让想法产生更多想法,创新激发更多创新。